two new therapies for advanced breast cancer
February 1996
Zeneca will be promoting two new therapies for advanced breast cancer...Zoladex (goserelin implant) and Arimidex (anastrozole).
Zoladex is already on the market for treating prostate cancer and endometriosis.
Now it's also approved for metastatic breast cancer...in women who have NOT yet gone through menopause.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote